Newtyn Management, LLC
- SEC CIK
- 0001569241
No open-market purchases or sales filed in the past year.
Current role at each company
- Pacific Gas & Electric Co10% Owneras of Feb 3, 2023
- MACK Merrimack Pharmaceuticals IncOther: See Remarksas of Jan 17, 2023
- FLXN Flexion Therapeutics Inc10% Owneras of Nov 23, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Newtyn Management, LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
Pacific Gas & Electric Co
10% Owner107 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2023 (view filing) | Feb 1-2 | 2 days | Newtyn Management, LLC10% Owner | SSaleFirst pref stock, par value $25, 6% nonredeemable | −30.4K | $22.24 | −$676.9K | −16.7%151.4K after | 2 lots |
| Feb 3, 2023 (view filing) | Feb 1-2 | 2 days | Newtyn Management, LLC10% Owner | SSaleFirst pref stock, par value $25, 5.50% nonredeemable | −1.90K | $19.94 | −$37.9K | −0.8%240.5K after | 2 lots |
| Feb 3, 2023 (view filing) | Feb 1-2 | 2 days | Newtyn Management, LLC10% Owner | SSaleFirst pref stock, par value $25, 5% redeemable | −2.15K | $17.99 | −$38.7K | −1.4%150.5K after | 2 lots |
| Feb 3, 2023 (view filing) | Feb 1-2 | 2 days | Newtyn Management, LLC10% Owner | SSaleFirst pref stock, par value $25, 4.36% series A redeemable | −1.50K | $16.19 | −$24.3K | −1.4%103.0K after | 2 lots |
| Feb 3, 2023 (view filing) | Feb 2 | 1 day | Newtyn Management, LLC10% Owner | SSaleFirst pref stock, par value $25, 5% series A redeemable | −4.93K | $17.87 | −$88.1K | −7.0%65.1K after | |
| Feb 1, 2023 (view filing) | Jan 30-31 | 2 days | Newtyn Management, LLC10% Owner | SSaleFirst pref stock, par value $25, 6% nonredeemable | −4.71K | $22.07 | −$104.0K | −2.5%181.8K after | 2 lots |
| Feb 1, 2023 (view filing) | Jan 30 | 2 days | Newtyn Management, LLC10% Owner | SSaleFirst pref stock, par value $25, 5% series A redeemable | −2.00K | $17.60 | −$35.2K | −2.8%70.0K after | |
| Feb 1, 2023 (view filing) | Jan 30-31 | 2 days | Newtyn Management, LLC10% Owner | SSaleFirst pref stock, par value $25, 4.80% redeemable | −3.00K | $17.45 | −$52.4K | −2.2%135.8K after | 2 lots |
| Feb 1, 2023 (view filing) | Jan 31 | 1 day | Newtyn Management, LLC10% Owner | SSaleFirst pref stock, par value $25, 5.50% nonredeemable | −500 | $19.62 | −$9.81K | −0.2%242.4K after | |
| Jan 30, 2023 (view filing) | Jan 26-27 | 4 days | Newtyn Management, LLC10% Owner | SSaleFirst pref stock, par value $25, 6% nonredeemable | −11.0K | $22.15 | −$243.7K | −5.6%186.5K after | 2 lots |
MACK Merrimack Pharmaceuticals Inc
Other: See Remarks14 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2023 (view filing)4:05 PM ET | Jan 12 | 5 days | Levy Noah G. and 5 othersDirector, Other: See remarks | PPurchase | +100.0K | $11.90 | +$1.19M | +9.8%1.12M after | |
| Jan 4, 2023 (view filing)4:06 PM ET | Dec 30, 2022-Jan 3, 2023 | 5 days | Levy Noah G. and 5 othersDirector, Other: See remarks | PPurchase | +6.60K | $11.24 | +$74.2K | +0.7%1.02M after | 2 lots |
| Jul 15, 2022 (view filing)4:05 PM ET | Jul 13 | 2 days | Levy Noah G. and 5 othersDirector, Other: See remarks | PPurchase | +3.10K | $5.89 | +$18.2K | +0.4%754.1K after | |
| Jul 13, 2022 (view filing)4:05 PM ET | Jul 11-12 | 2 days | Levy Noah G. and 5 othersDirector, Other: See remarks | PPurchase | +3.52K | $5.89 | +$20.7K | +0.5%751.0K after | 2 lots |
| Jul 11, 2022 (view filing)4:05 PM ET | Jul 7-8 | 4 days | Levy Noah G. and 5 othersDirector, Other: See remarks | PPurchase | +2.48K | $5.99 | +$14.8K | +0.3%747.5K after | 2 lots |
| Jul 5, 2022 (view filing)4:06 PM ET | Jun 30 | 5 days | Levy Noah G. and 5 othersDirector, Other: See remarks | PPurchase | +1.55K | $5.76 | +$8.92K | +0.2%745.0K after | |
| Jun 27, 2022 (view filing)4:05 PM ET | Jun 23-24 | 4 days | Levy Noah G. and 5 othersDirector, Other: See remarks | PPurchase | +1.50K | $5.99 | +$8.99K | +0.2%743.5K after | 2 lots |
| Jun 21, 2022 (view filing)4:05 PM ET | Jun 16-17 | 5 days | Levy Noah G. and 5 othersDirector, Other: See remarks | PPurchase | +1.42K | $5.78 | +$8.21K | +0.2%742.0K after | 4 lots |
| Jun 16, 2022 (view filing)4:05 PM ET | Jun 14-15 | 2 days | Levy Noah G. and 5 othersDirector, Other: See remarks | PPurchase | +23.8K | $5.20 | +$123.9K | +3.3%741.4K after | 4 lots |
| Jun 14, 2022 (view filing)4:05 PM ET | Jun 10-13 | 4 days | Levy Noah G. and 5 othersDirector, Other: See remarks | PPurchase | +16.1K | $5.06 | +$81.4K | +2.2%731.2K after | 4 lots |